Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Nov 2018 for Corium International, Inc., €103.2M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Ronald W. Eastman: trading record in brief
Filings by Ronald W. Eastman span 2 companies, the busiest being Corium International, Inc. and Revance Therapeutics, Inc. We count 2 filings; the first trade dates from 11 May 2017 and the latest from 27 November 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 29 November 2018 came the latest disclosure, a transaction for €103.2M in Corium International, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ronald W. Eastman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
●
Same trade as the filing by Essex Woodlands Health Ventures Fund VII LP, counted once
117M USD19SEC
9,353,304 shares@ US$12.50100.0% of flowCommon StockSEC:0001567619-18-007097:0
3,000 shares0Common StockSEC:0001209191-17-032205:0
2 of 1 declaration
